跳至主要内容
临床试验/NCT04491864
NCT04491864终止不适用

DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2019年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
11
试验地点
1
主要终点
MRI DWIBS Accuracy

研究概览

简要总结

1.1. Primary Objectives

  • To determine if MRI DWIBS can accurately identify suspicious lesions previously categorized on mammography and sonography as potentially malignant.
  • We will also validate whether DWIBS-MRI ADC values can be used to accurately differentiate benign from malignant lesions. Additionally, because it is not known whether tumor type or growth rate (Ki67 values) will affect our results, we will include these parameters in our analysis.
  • Once we validate the use of DWIBS-MRI ADC values to determine malignancy, can we establish an ADC threshold value to decrease the number of false positive biopsies that are performed while still maintaining a zero false negative rate?
  • This study will also assess the correlation between ADC values and the Ki-67 proliferative index of malignant lesions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A patient will be eligible for inclusion in this study if she meets all of the following criteria:
  • >30 years of age
  • Genetic Female
  • Suspected diagnosis of BIRADS 4 or BIRADS 5 masses and/or asymmetries greater than 1 centimeter based on standard 2D/3D mammogram and ultrasound imaging.

排除标准

  • A patient is ineligible for inclusion in this study if she meets any of the following criteria:
  • Prior biopsy of suspicious lesion
  • Breast implants
  • Prior history of breast cancer
  • Patient has a pacemaker
  • Contraindications to use of MRI imaging (metal implants, etc.)
  • Woman pregnant or lactating
  • Calcifications as only findings present for a suspicious lesion

结局指标

主要结局

MRI DWIBS Accuracy

时间窗: 1 month

• To determine if MRI DWIBS can accurately identify suspicious lesions previously categorized on mammography and sonography as potentially malignant.

Validate DWIBS-MRI

时间窗: 1 month

• We will also validate whether DWIBS-MRI ADC values can be used to accurately differentiate benign from malignant lesions. Additionally, because it is not known whether tumor type or growth rate (Ki67 values) will affect our results, we will include these parameters in our analysis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor
主要研究者

Sean Raj

Medical Doctor

Baylor Research Institute

研究点 (1)

Loading locations...

相似试验